FARZANA WAKIL: Open Payments
NPI 1679230114 · RICHARDSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$848 in 18 payments from 8 companies in 2025. Trend: 2023 $202 · 2024 $490 · 2025 $848
Food & beverage: $848
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 4 | $229 |
| Ardelyx, Inc. | 6 | $181 |
| Ipsen Biopharmaceuticals, Inc | 1 | $150 |
| Medtronic, Inc. | 1 | $116 |
| CONMED Corporation | 1 | $63 |
| ABBVIE INC. | 3 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| GENZYME CORPORATION | 1 | $22 |
Products named: REZDIFFRA, IBSRELA, IQIRVO, DRAGONFLY PANCREATICOBILIARY SCOPE AND INSTRUMENT CHANNEL CAPS, CONMED GENERATORS, CREON, ENTYVIO, DUPIXENT.
Industry payments across TX — which companies pay providers there.
